These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Efficacy of pefloxacin in the treatment of postoperative sepsis in gynaecology. Arowojolu AO; Bakare RA; Oni AA; Ayodele AE; Kayode OO Afr J Med Med Sci; 1999; 28(3-4):151-3. PubMed ID: 11205820 [TBL] [Abstract][Full Text] [Related]
28. [Use of pefloxacin in the treatment of infected burn wounds]. Iakovlev VP; Alekseev AA; Krutikov MG; Grishina IA; Izotova GN Antibiot Khimioter; 1996 Jun; 41(6):39-43. PubMed ID: 9054328 [TBL] [Abstract][Full Text] [Related]
29. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009. Dowzicky MJ Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154 [TBL] [Abstract][Full Text] [Related]
30. [Activity of fluoroquinolones studied on a model of suppurative meningoencephalitis caused by Pseudomonas aeruginosa in mice]. Padeĭskaia EN; Mnatsakanian VE Antibiot Khimioter; 1991 Jul; 36(7):25-8. PubMed ID: 1953184 [TBL] [Abstract][Full Text] [Related]
31. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations]. Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897 [TBL] [Abstract][Full Text] [Related]
32. [Use of pefloxacin in the treatment of patients with purulent wounds of soft tissues]. Blatun LA; Puchkova LS; Navashin PS; Iakovlev VP; Svetykhin AM Antibiot Khimioter; 1999; 44(1):20-2. PubMed ID: 10095920 [TBL] [Abstract][Full Text] [Related]
33. Intraaortic vegetations and infective endocarditis. O'Sullivan CE N Engl J Med; 2007 Jun; 356(23):2430-1; author reply 2430-1. PubMed ID: 17561534 [No Abstract] [Full Text] [Related]
34. [Prolonged treatment with linezolid with good hematologic tolerability]. Ramos A; García MJ; Blasco F; Valverde ML Rev Esp Quimioter; 2004 Sep; 17(3):266-7. PubMed ID: 15619657 [No Abstract] [Full Text] [Related]
35. [Pefloxacin in the treatment of patients with mucoviscidosis]. Postnikov SS; Semykin SIu; Polikarpova SV; Nazhimov VP Antibiot Khimioter; 2002; 47(4):13-5. PubMed ID: 12369138 [TBL] [Abstract][Full Text] [Related]
36. Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria. Yan ST; Sun LC; Jia HB; Gao W; Yang JP; Zhang GQ Am J Emerg Med; 2017 Apr; 35(4):579-583. PubMed ID: 27979420 [TBL] [Abstract][Full Text] [Related]
37. Protective role of the pefloxacin-IFN-gamma association in Leishmania major-infected mice. Zucca M; Millesimo M; Giovarelli M; Diverio D; Musso T; Savoia D New Microbiol; 1996 Jan; 19(1):39-46. PubMed ID: 8673851 [TBL] [Abstract][Full Text] [Related]
38. Genotyping, antimicrobial resistance and virulence factor gene profiles of vancomycin resistance Enterococcus faecalis isolated from blood culture. Armin S; Fallah F; Karimi A; Rashidan M; Shirdust M; Azimi L Microb Pathog; 2017 Aug; 109():300-304. PubMed ID: 28578090 [TBL] [Abstract][Full Text] [Related]
39. Reconsidering isolation precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Morgan DJ; Kaye KS; Diekema DJ JAMA; 2014 Oct; 312(14):1395-6. PubMed ID: 25291571 [No Abstract] [Full Text] [Related]
40. Multidrug-Resistant Enterococcal Infections: New Compounds, Novel Antimicrobial Therapies? van Harten RM; Willems RJL; Martin NI; Hendrickx APA Trends Microbiol; 2017 Jun; 25(6):467-479. PubMed ID: 28209400 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]